 Abigail Lara
Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arginine | 3 | 2017 | 271 | 0.590 |
Why?
| | Nitric Oxide | 4 | 2017 | 915 | 0.470 |
Why?
| | Lymphatic Vessels | 1 | 2012 | 64 | 0.380 |
Why?
| | Collagen | 2 | 2012 | 452 | 0.350 |
Why?
| | Arginase | 1 | 2008 | 32 | 0.290 |
Why?
| | Fibroblasts | 1 | 2012 | 996 | 0.270 |
Why?
| | Lung Diseases, Interstitial | 2 | 2012 | 638 | 0.260 |
Why?
| | Hemorrhage | 1 | 2010 | 722 | 0.240 |
Why?
| | Severity of Illness Index | 1 | 2012 | 2828 | 0.220 |
Why?
| | Lung Diseases | 1 | 2010 | 767 | 0.210 |
Why?
| | Pulmonary Fibrosis | 3 | 2011 | 402 | 0.200 |
Why?
| | Pulmonary Artery | 2 | 2007 | 1086 | 0.200 |
Why?
| | Asthma | 3 | 2017 | 2295 | 0.190 |
Why?
| | Bronchoalveolar Lavage | 2 | 2013 | 93 | 0.180 |
Why?
| | Bleomycin | 2 | 2011 | 248 | 0.160 |
Why?
| | Biopsy | 3 | 2013 | 1129 | 0.160 |
Why?
| | Idiopathic Pulmonary Fibrosis | 2 | 2016 | 657 | 0.130 |
Why?
| | Hypertension, Pulmonary | 3 | 2011 | 1910 | 0.120 |
Why?
| | Cholestyramine Resin | 1 | 2015 | 7 | 0.120 |
Why?
| | Bronchi | 1 | 2017 | 260 | 0.120 |
Why?
| | Isoxazoles | 1 | 2015 | 54 | 0.120 |
Why?
| | Case-Control Studies | 4 | 2012 | 3556 | 0.120 |
Why?
| | Prosthesis-Related Infections | 1 | 2015 | 95 | 0.110 |
Why?
| | Breath Tests | 2 | 2017 | 87 | 0.110 |
Why?
| | Mucin-5B | 1 | 2016 | 224 | 0.100 |
Why?
| | Shock, Septic | 1 | 2015 | 219 | 0.100 |
Why?
| | Vascular Endothelial Growth Factor D | 1 | 2012 | 13 | 0.100 |
Why?
| | Silicosis | 1 | 2013 | 27 | 0.100 |
Why?
| | Vascular Endothelial Growth Factor C | 1 | 2012 | 17 | 0.100 |
Why?
| | Antirheumatic Agents | 1 | 2015 | 293 | 0.100 |
Why?
| | Lymphangiogenesis | 1 | 2012 | 27 | 0.100 |
Why?
| | Transforming Growth Factor beta | 2 | 2012 | 480 | 0.100 |
Why?
| | Anesthesia, General | 1 | 2013 | 77 | 0.100 |
Why?
| | Lung Injury | 2 | 2011 | 219 | 0.090 |
Why?
| | Myofibroblasts | 1 | 2012 | 127 | 0.090 |
Why?
| | Promoter Regions, Genetic | 1 | 2016 | 1250 | 0.090 |
Why?
| | Lactic Acid | 1 | 2012 | 305 | 0.090 |
Why?
| | Gene Expression | 1 | 2016 | 1502 | 0.090 |
Why?
| | Lung | 3 | 2013 | 4060 | 0.090 |
Why?
| | Plasmapheresis | 1 | 2010 | 24 | 0.080 |
Why?
| | Radiography | 1 | 2012 | 822 | 0.080 |
Why?
| | Spirometry | 2 | 2008 | 281 | 0.080 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2012 | 545 | 0.080 |
Why?
| | Biological Availability | 1 | 2008 | 148 | 0.070 |
Why?
| | Pulmonary Alveoli | 1 | 2010 | 405 | 0.070 |
Why?
| | Respiration, Artificial | 2 | 2013 | 645 | 0.070 |
Why?
| | Adrenal Cortex Hormones | 1 | 2010 | 565 | 0.060 |
Why?
| | Receptors, Immunologic | 1 | 2007 | 216 | 0.060 |
Why?
| | Immunosuppressive Agents | 1 | 2010 | 890 | 0.060 |
Why?
| | Mitral Valve Insufficiency | 1 | 2005 | 68 | 0.060 |
Why?
| | Cell Differentiation | 1 | 2012 | 1991 | 0.060 |
Why?
| | Humans | 15 | 2017 | 137585 | 0.060 |
Why?
| | Lung Transplantation | 1 | 2007 | 313 | 0.050 |
Why?
| | Male | 10 | 2017 | 67762 | 0.050 |
Why?
| | Female | 11 | 2017 | 73304 | 0.050 |
Why?
| | Myocardial Ischemia | 1 | 2005 | 263 | 0.050 |
Why?
| | Cell Proliferation | 1 | 2011 | 2475 | 0.050 |
Why?
| | Kidney Calculi | 1 | 2003 | 38 | 0.050 |
Why?
| | Superoxide Dismutase | 1 | 2005 | 346 | 0.050 |
Why?
| | T-Lymphocytes | 1 | 2011 | 1996 | 0.050 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2005 | 382 | 0.050 |
Why?
| | Sulfonamides | 1 | 2005 | 513 | 0.050 |
Why?
| | Antihypertensive Agents | 1 | 2005 | 494 | 0.040 |
Why?
| | Glycolysis | 2 | 2017 | 321 | 0.040 |
Why?
| | Polymerase Chain Reaction | 2 | 2016 | 1062 | 0.040 |
Why?
| | Endothelium, Vascular | 1 | 2007 | 927 | 0.040 |
Why?
| | Aged | 4 | 2015 | 23961 | 0.040 |
Why?
| | Middle Aged | 5 | 2012 | 33479 | 0.040 |
Why?
| | Respiratory Insufficiency | 2 | 2013 | 318 | 0.040 |
Why?
| | Kidney Failure, Chronic | 1 | 2003 | 570 | 0.030 |
Why?
| | Exhalation | 1 | 2017 | 39 | 0.030 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2017 | 173 | 0.030 |
Why?
| | Adult | 5 | 2017 | 37929 | 0.030 |
Why?
| | Kidney Transplantation | 1 | 2003 | 708 | 0.030 |
Why?
| | Acute Kidney Injury | 1 | 2003 | 815 | 0.030 |
Why?
| | Renal Replacement Therapy | 1 | 2015 | 92 | 0.030 |
Why?
| | Respiratory Mucosa | 1 | 2017 | 321 | 0.030 |
Why?
| | One-Lung Ventilation | 1 | 2013 | 5 | 0.030 |
Why?
| | Pulmonary Alveolar Proteinosis | 1 | 2013 | 17 | 0.030 |
Why?
| | Lung Compliance | 1 | 2011 | 49 | 0.020 |
Why?
| | Chemokine CXCL1 | 1 | 2011 | 76 | 0.020 |
Why?
| | Trauma Severity Indices | 1 | 2011 | 106 | 0.020 |
Why?
| | Intubation, Intratracheal | 1 | 2013 | 257 | 0.020 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2011 | 198 | 0.020 |
Why?
| | Mice, Inbred C57BL | 2 | 2011 | 5757 | 0.020 |
Why?
| | Acute Disease | 1 | 2013 | 1007 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 852 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2011 | 652 | 0.020 |
Why?
| | Receptor for Advanced Glycation End Products | 1 | 2007 | 33 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2015 | 10811 | 0.020 |
Why?
| | Survival Analysis | 1 | 2010 | 1325 | 0.020 |
Why?
| | Survival Rate | 1 | 2011 | 1972 | 0.020 |
Why?
| | Sex Characteristics | 1 | 2011 | 762 | 0.020 |
Why?
| | Hypoxia | 1 | 2013 | 1112 | 0.020 |
Why?
| | DNA Primers | 1 | 2007 | 515 | 0.020 |
Why?
| | Glutathione Peroxidase | 1 | 2005 | 43 | 0.010 |
Why?
| | Sex Factors | 1 | 2011 | 2071 | 0.010 |
Why?
| | Cicatrix | 1 | 2005 | 64 | 0.010 |
Why?
| | Mitral Valve | 1 | 2005 | 88 | 0.010 |
Why?
| | Linear Models | 1 | 2007 | 849 | 0.010 |
Why?
| | Adenosine Triphosphate | 1 | 2007 | 491 | 0.010 |
Why?
| | Anuria | 1 | 2003 | 4 | 0.010 |
Why?
| | Proteus mirabilis | 1 | 2003 | 3 | 0.010 |
Why?
| | Proteus Infections | 1 | 2003 | 5 | 0.010 |
Why?
| | Mice | 2 | 2011 | 17787 | 0.010 |
Why?
| | Age Factors | 1 | 2011 | 3295 | 0.010 |
Why?
| | Forced Expiratory Volume | 1 | 2005 | 531 | 0.010 |
Why?
| | Glutathione | 1 | 2005 | 356 | 0.010 |
Why?
| | Airway Obstruction | 1 | 2005 | 162 | 0.010 |
Why?
| | Respiratory Function Tests | 1 | 2005 | 600 | 0.010 |
Why?
| | Base Sequence | 1 | 2007 | 2181 | 0.010 |
Why?
| | Transplantation, Homologous | 1 | 2003 | 416 | 0.010 |
Why?
| | Echocardiography | 1 | 2005 | 642 | 0.010 |
Why?
| | Oxygen | 1 | 2007 | 931 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2007 | 2031 | 0.010 |
Why?
| | Intensive Care Units | 1 | 2007 | 827 | 0.010 |
Why?
| | Length of Stay | 1 | 2007 | 1215 | 0.010 |
Why?
| | Amino Acids | 1 | 2005 | 497 | 0.010 |
Why?
| | Pneumonia | 1 | 2007 | 639 | 0.010 |
Why?
| | Energy Metabolism | 1 | 2007 | 922 | 0.010 |
Why?
| | Mitochondria | 1 | 2007 | 948 | 0.010 |
Why?
| | Heart Ventricles | 1 | 2005 | 788 | 0.010 |
Why?
| | Retrospective Studies | 2 | 2010 | 15657 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2007 | 4193 | 0.010 |
Why?
| | Coronary Artery Disease | 1 | 2005 | 698 | 0.010 |
Why?
| | Animals | 2 | 2011 | 36940 | 0.010 |
Why?
| | Prognosis | 1 | 2007 | 4030 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2005 | 1317 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2010 | 7635 | 0.010 |
Why?
| | Cohort Studies | 1 | 2007 | 5742 | 0.010 |
Why?
| | Biomarkers | 1 | 2007 | 4149 | 0.010 |
Why?
| | Prospective Studies | 1 | 2007 | 7604 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2005 | 3566 | 0.010 |
Why?
|
|
Lara's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|